文献速递妇幼与学校卫生传染病防控与疫情报告

母亲孕前乙型肝炎病毒感染与早产风险:一项基于人群的队列研究

Maternal pre-pregnancy infection with hepatitis B virus and the risk of preterm birth: a population-based cohort study.
PubMed 文献 · Lancet Glob Health · 2017-01-01

该研究基于中国220个县489965名农村单胎活产妇女,按孕前乙肝病毒感染状态分三组,发现HBsAg阳性/HBeAg阴性者早产风险aRR 1.26(95%CI 1.18-1.34),HBsAg和HBeAg均阳性者aRR 1.20(1.08-1.32),早期早产风险亦升高。

要点

  • 孕前HBsAg阳性/HBeAg阴性者早产风险较未感染者高26%(aRR 1.26,95%CI 1.18-1.34)。
  • 孕前HBsAg和HBeAg均阳性者早产风险较未感染者高20%(aRR 1.20,95%CI 1.08-1.32)。
  • 孕前乙肝感染与早产独立相关,作者建议孕前早期检测并给予适当医疗干预。

核心结论

  • 除母婴传播外,乙肝病毒感染妇女的早产风险不应被忽视。
  • 作者认为,关注孕前乙肝早期检测并为感染妇女提供适当医疗干预的综合规划有助于改善母婴结局和降低儿童死亡率。

研究设计与样本

  • 基于人群的队列研究,使用2010年1月1日至2012年12月31日中国220个县参与国家免费孕前健康检查项目的489965名21-49岁农村单胎活产妇女数据。
  • 按孕前乙肝病毒感染状态分为三组:未感染对照组、HBsAg阳性且HBeAg阴性暴露组1、HBsAg和HBeAg均阳性暴露组2。
  • 主要结局为早产(妊娠不足37周),使用对数二项回归估计调整风险比(aRR)。

主要发现

  • 489965名妇女纳入研究,其中20827名(4.3%)感染乙肝病毒。
  • 与未感染妇女相比,HBsAg阳性且HBeAg阴性妇女早产风险升高26%(aRR 1.26,95%CI 1.18-1.34),HBsAg和HBeAg均阳性妇女早产风险升高20%(aRR 1.20,95%CI 1.08-1.32)。
  • 与未感染妇女相比,HBsAg阳性且HBeAg阴性妇女早期早产(妊娠不足34周)风险升高18%(aRR 1.18,95%CI 1.04-1.34),HBsAg和HBeAg均阳性妇女早期早产风险升高34%(aRR 1.34,95%CI 1.10-1.61)。
  • 孕前乙肝病毒感染与早产及早期早产风险升高独立相关,且在各基线特征亚组中关联相似。

临床怎么用

  • 作者认为,应关注孕前乙肝病毒感染妇女的早产风险,而不仅是母婴传播。
  • 作者建议,综合规划应聚焦孕前乙肝病毒感染的早期检测,并为感染妇女在孕前和孕期提供适当医疗干预。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Preterm birth is the leading cause of child death in children younger than 5 years. Large cohort studies in developed countries have shown that maternal hepatitis B virus infection is associated with preterm birth, but there is little reliable evidence from China and other developing countries, where hepatitis B virus prevalence is intermediate or high. Hence, we designed this study to investigate the association between pre-pregnancy hepatitis B virus infection and risk of preterm and early preterm birth. METHODS: Between Jan 1, 2010, and Dec 31, 2012, we did a population-based cohort study using data from 489 965 rural women aged 21-49 years who had singleton livebirths from 220 counties of China who participated in the National Free Preconception Health Examination Project. Participants were divided into three groups according to their pre-pregnancy status of hepatitis B virus infection: women uninfected with hepatitis B virus (control group), women who were HBsAg positive and HBeAg negative (exposure group 1), and women who were both HBsAg and HBeAg positive (exposure group 2). The primary outcome was preterm birth (gestation at less than 37 weeks). We used log-binomial regression to estimate adjusted risk ratios (aRR) of preterm birth for women with pre-pregnancy hepatitis B virus infection, and risk of early preterm birth (gestation less than 34 weeks). FINDINGS: 489 965 women met inclusion criteria and were included in this study; of these, 20 827 (4·3%) were infected with hepatitis B virus. Compared with women who were not infected with hepatitis B virus, women who were HBsAg positive and HBeAg negative had a 26% higher risk of preterm birth (aRR 1·26, 95% CI 1·18-1·34) and women who were both HBsAg and HBeAg positive had a 20% higher risk of preterm birth (aRR 1·20, 1·08-1·32). Compared with women who were not infected with hepatitis B virus, women who were HBsAg positive and HBeAg negative manifested an 18% higher risk of early preterm birth (gestation less than 34 weeks; aRR 1·18, 1·04-1·34) and women who were both HBsAg and HBeAg positive had a 34% higher risk of early preterm birth (aRR 1·34, 1·10-1·61). Maternal pre-pregnancy hepatitis B virus infection was independently associated with higher risk of preterm birth and early preterm birth. These associations were similar in subgroups of participants as defined by baseline characteristics. INTERPRETATION: Besides mother-to-child transmission, the risk of preterm birth in women infected with hepatitis B virus should not be neglected. Comprehensive programmes that focus on early detection of hepatitis B virus infection before pregnancy and provide appropriate medical intervention for women infected with hepatitis B virus before and during pregnancy would be helpful in improving maternal and neonatal outcomes and reducing child mortality. FUNDING: Chinese Association of Maternal and Child Health Studies.

来源:Lancet Glob Health,查看原文。版权归原作者所有。

引用

  1. Liu J, Zhang S, Liu M, et al. Maternal pre-pregnancy infection with hepatitis B virus and the risk of preterm birth: a population-based cohort study. Lancet Glob Health. 2017. PMID: 28495266. doi:10.1016/S2214-109X(17)30142-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。